Benedict XVI returns to Vatican for first time

FILE- In this March 23, 2013 file photo provided by the Vatican paper L'Osservatore Romano, Pope Francis, right, and Pope emeritus Benedict XVI meet in Castel Gandolfo. Vatican spokesman, the Rev. Federico Lombardi said Tuesday April 30, 2013 that retired Pope Benedict XVI is moving into his new retirement home in the Vatican gardens on Thursday. Benedict has been living at the papal residence in Castel Gandolfo, in the hills south of Rome, ever since he resigned on Feb. 28 (AP Photo/Osservatore Romano, HO)

FILE- In this March 23, 2013 file photo provided by the Vatican paper L'Osservatore Romano, Pope Francis, right, and Pope emeritus Benedict XVI meet in Castel Gandolfo. Vatican spokesman, the Rev. Federico Lombardi said Tuesday April 30, 2013 that retired Pope Benedict XVI is moving into his new retirement home in the Vatican gardens on Thursday. Benedict has been living at the papal residence in Castel Gandolfo, in the hills south of Rome, ever since he resigned on Feb. 28 (AP Photo/Osservatore Romano, HO)

FILE - This Feb. 12, 2013 file photo shows a view of the Mater Ecclesiae Monastery inside the Vatican State where Pope Benedict XVI is expected to live after he resigns, on Tuesday, Feb. 12, 2013. Vatican spokesman, the Rev. Federico Lombardi said Tuesday April 30, 2013 that retired Pope Benedict XVI is moving into his new retirement home in the Vatican gardens on Thursday. Benedict has been living at the papal residence in Castel Gandolfo, in the hills south of Rome, ever since he resigned on Feb. 28. (AP Photo/Alessandra Tarantino, file)

FILE - Pope Benedict XVI leaves after greeting the faithful from the balcony window of the papal summer residence of Castel Gandolfo, the scenic town where he will spend his first post-Vatican days and made his last public blessing as pope,Thursday, Feb. 28, 2013. Vatican spokesman, the Rev. Federico Lombardi said Tuesday April 30, 2013 that retired Pope Benedict XVI is moving into his new retirement home in the Vatican gardens on Thursday. Benedict has been living at the papal residence in Castel Gandolfo, in the hills south of Rome, ever since he resigned on Feb. 28. (AP Photo/Alessandra Tarantino, file)

VATICAN CITY (AP) ? Emeritus Pope Benedict XVI came home to the Vatican on Thursday for the first time since he resigned Feb. 28, beginning an unprecedented era for the Catholic Church of having a retired pontiff living alongside a reigning one.

Pope Francis welcomed Benedict outside his new retirement home ? a converted monastery on the edge of the Vatican gardens ? and the two immediately went into the adjoining chapel to pray together, the Vatican said.

The Vatican said Benedict, 86, was pleased to be back and that he would ? as he himself has said ? "dedicate himself to the service of the church with prayer." Francis, the statement said, welcomed him with "brotherly cordiality."

Unlike the live, door-to-door Vatican-provided television coverage that accompanied Benedict's emotional farewell in February, the Vatican provided no television images of his return Thursday.

The low-key return followed the remarkable yet somewhat alarming images transmitted on March 23 when Francis went to visit Benedict at the papal retreat in Castel Gandolfo, south of Rome, where Benedict was living. In that footage, Benedict appeared visibly more frail and thinner only three weeks after resigning.

Some Vatican officials questioned whether those images should have been released, given how frail Benedict appeared.

The Vatican spokesman, the Rev. Federico Lombardi, has acknowledged Benedict's post-retirement decline but has insisted the 86-year-old German isn't suffering from any specific ailment and is just old.

"He is a man who is not young: He is old and his strength is slowly ebbing," Lombardi said this week. "However, there is no special illness. He is an old man who is healthy."

Benedict chose to leave the Vatican immediately after his resignation to physically remove himself from the process of electing his successor and from Pope Francis' first weeks as pontiff.

His absence also gave workers time to finish up renovations on the monastery tucked behind St. Peter's Basilica that until last year housed groups of cloistered nuns who were invited for a few years at a time to live inside the Vatican to pray.

In the compact, four-story building, Benedict will live with his personal secretary, Monsignor Georg Gaenswein, and the four consecrated women who look after him, preparing his meals and tending to the household. The building also has a small library, a study and a guest room for when his brother, Monsignor Georg Ratzinger, comes to visit.

"It is certainly small but well-equipped," Lombardi said.

When Benedict announced his intention to resign ? the first pontiff to do so in 600 years ? questions immediately swirled about the implications of having two popes living alongside one another inside the Vatican.

Benedict fueled those concerns when he chose to be called "emeritus pope" and "Your Holiness" rather than "emeritus bishop of Rome." He also raised eyebrows when he chose to continue wearing the white cassock of the papacy.

Given the political intrigues that plague the Vatican, it wasn't much of a stretch of the imagination to wonder if some cardinals, bishops and monsignors ? not to mention ordinary Catholics ? might continue making Benedict their point of reference rather than the new pope.

But Benedict made clear on his final day as pope that he was renouncing the job and pledged his "unconditional reverence and obedience" to his then-unknown successor. It was a pledge he repeated in person on March 23 when Francis went to have lunch with him.

It was during that visit that the world saw how weak Benedict had become: Always a man with a purposeful walk, he shuffled tentatively that day, using his cane.

Francis, for his part, seems utterly unfazed by the novel situation. He has frequently invoked Benedict's name and work and has called him on a half-dozen occasions, making clear he has no intention of ignoring the fact that there's another pope still very much alive and now living on the other side of the garden.

Francis' gestures to Benedict during that March 23 visit were also remarkable: He refused to pray on the special papal kneeler in the small chapel of Castel Gandolfo, preferring to join Benedict on a kneeler in the pews, and referring to his predecessor as his "brother."

Now that they're neighbors, they might bump into one another on walks in the Vatican gardens or at the shrine to the Madonna, which is just a stone's throw from Benedict's new home.

___

Follow Nicole Winfield at www.twitter.com/nwinfield

Associated Press

Source: http://hosted2.ap.org/apdefault/cae69a7523db45408eeb2b3a98c0c9c5/Article_2013-05-02-Vatican-Benedict/id-83759f48d4514d97887b5c8fc9c2c212

adrienne rich autism cesar chavez day raspberry ketone ron burgundy millennial media nit championship

CBS' Moonves dismisses Aereo as 1Q earns top views

LOS ANGELES (AP) ? CBS Corp. Chief Executive Les Moonves gave an upbeat view of the health of broadcast TV Wednesday as the company reported strong results for the first three months of the year. He also dismissed startup Aereo as an "insignificant player" that was stealing CBS' signal.

Moonves told investors that Aereo has "gotten way too much attention" from the news media. The New York-based company takes broadcast signals for free from the airwaves and charges customers to watch them over computers and mobile devices. That threatens CBS' ability to collect fees from traditional service providers such as cable TV for rights to redistribute its stations' signals.

"We're not losing sleep over it. It is an insignificant player that has a couple thousand (subscribers)," Moonves said on a conference call. "We think ultimately that it goes away."

Broadcasters such as CBS have sued Aereo for copyright infringement, but so far Aereo has managed to keep operating thanks to a preliminary ruling in its favor last month. The company captures signals using thousands of tiny antennas, which it argues is comparable to individuals buying digital antennas for themselves.

Moonves echoed the comments of News Corp. Chief Operating Officer Chase Carey, who said last month that if Aereo gets a legal OK to keep operating, he would consider changing the Fox network to a channel available only through cable and satellite TV services.

Moonves said that making this switch at CBS would be "fairly easy to do" and not that disruptive because 85 percent of people who watch CBS do so through TV providers such as cable and satellite companies. But he added, "I'm very doubtful that happens."

Moonves' comments came as CBS, the maker of shows such as "NCIS: Los Angeles" and "The Good Wife," reported that first-quarter earnings rose 22 percent to $443 million, or 69 cents per share. Excluding a loss from the outdoor billboard business in Europe and Asia, which CBS expects to sell this year, adjusted earnings came to 73 cents per share, 5 cents better than the 68 cents predicted by analysts polled by FactSet.

Revenue rose 6 percent to $4.04 billion, the highest since the company's 2006 split from Viacom Inc. That topped the $4.02 billion expected by analysts.

Advertising revenue grew 8 percent to $2.46 billion, helped by big events such as the Super Bowl and Grammy awards. Excluding these one-time events, the company said ad revenue would have grown in the "low single digit" percentages.

CBS Corp.'s stock rose 50 cents, or 1.1 percent, in after-hours trading to $46.90.

Moonves said that demand for last-minute ad buys on the CBS network was strong. He predicted that both bulk airtime sales and prices would be "up considerably" during the mass sales period ongoing now called the "upfronts." Such price hikes would boost CBS's finances in the final quarter of the year. He said prices would be up in the "high single to low double digit" percentages from a year ago.

Alan Gould, an analyst with investment bank Evercore Partners, said Moonves' comments were reassuring. Gould said the quarterly results were much better than expected.

"I do believe him that CBS will do better than the rest of the industry," he said.

Earlier Wednesday, NBC and Telemundo owner Comcast Corp. said broadcast television revenue fell more than 18 percent to $1.5 billion because the quarter last year included the Super Bowl on NBC. Excluding the Super Bowl, which was on CBS this year, revenue fell 5 percent. Comcast blamed lower prime-time ratings at NBC and lower revenue from content licensing.

ABC and ESPN owner Walt Disney Co. and Fox owner News Corp. are scheduled to report results next week.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/495d344a0d10421e9baa8ee77029cfbd/Article_2013-05-01-US-Earns-CBS/id-b945e71269c2458c84cae7a9bc2e133f

may day amanda bynes reese witherspoon lil wayne Barcelona 747 crash Call Of Duty Ghosts

Andreessen: Android poised to explode in emerging markets

Bloomberg recently TV interviewed Marc Andreessen, the guy who’s famous for co-founding Netscape and currently works as a VC at his own Silicon Valley VC shop, Andreessen Horowitz.

Towards the end of the interview, he was asked what’s big for 2013. After saying that tablet growth would still be huge, he followed up with this quote:

"The other thing I think I'd point to is the $50 Android smartphone is about to hit the market worldwide. Smartphones are about to be put in the hands of another 3 billion people who don't have them. And that's probably the single biggest thing that's happening right now."

In the developed world, we tend to think of Android as Samsung Galaxy S3 and S4, the new HTC One, maybe some Sony, and throw Motorola in for good measure. Yeah, we hear about cheaper hardware, but rarely do we stop to think about what it means to emerging markets.

read more

Source: http://feedproxy.google.com/~r/androidcentral/~3/oiknIfBg26w/story01.htm

Ravi Shankar Geminid meteor shower right to work Clackamas Town Center 12 12 12 Anne Hathaway Wardrobe Malfunction Adrienne Maloof

Mayo Clinic finds experimental drug inhibits growth in all stages of common kidney cancer

Public release date: 30-Apr-2013
[ | E-mail | Share ]

Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic

JACKSONVILLE, Fla. Researchers at Mayo Clinic's campus in Florida have discovered a protein that is overly active in every human sample of kidney cancer they examined. They also found that an experimental drug designed to block the protein's activity significantly reduced tumor growth in animals when used alone. Combining it with another drug already used to treat the cancer improved the effectiveness of both.

The findings, reported in the April 30 online issue of Clinical Cancer Research, offer a much-needed potential new direction for the treatment of clear cell renal cell carcinoma, which accounts for almost 85 percent of kidney cancer cases in the United States. More than 57,000 diagnoses of kidney cancer occur yearly in the U.S. with greater than 13,000 deaths.

"There is a clear need for new therapies for this common cancer. With very few exceptions, patients inevitably become resistant to all available treatments," says the study's senior investigator, molecular biologist John Copland, Ph.D.

Their findings might be relevant to the treatment of other cancers, says Christina von Roemeling, the study's lead author. The protein they identified is produced by the stearoyl CoA desaturase 1 (SCD1) gene, which has also been found to be over active in a number of other cancers, including lung, stomach, breast, prostate, ovary and colon cancers.

"This is a gene that is highly active in a lot of other cancers and it may be that the agent we tested could provide new clinical avenues in those cancers as well," von Roemeling says.

The experimental drug, A939572, is a targeted inhibitor of SCD1 protein. "We found it to be incredibly specific to cancer cells in laboratory mice treated with the agent," Dr. Copland says. "But these are early days in the testing of this agent for cancer."

Not only is SCD1 active in some cancers, it also is being investigated for its role in promoting obesity and diabetes, the researchers say. Scientists are also testing A939572 as an antidote to those conditions.

The Mayo Clinic scientists performed a genome screen of tissue samples from 150 kidney cancer patient tissue samples, which represented all stages of cancer progression, to identify genes that are significantly overexpressed, compared to noncancerous tissue samples. SCD1 was one of their top finds.

They then disabled SCD1 in laboratory kidney cancer cells and found that the tumor cells stopped growing and a large percentage died.

Next, researchers tested A939572 and the federally approved kidney cancer drug temsirolimus. They found that using either agent alone cut tumor growth by up to 25 percent in mice studies, but using both drugs together, and at lower doses, reduced it 60 to 70 percent.

"The synergy between the drugs was very striking, suggestive of significant clinical benefit in patients," Dr. Copland says.

Von Roemeling says that SCD1 protein expression offers a novel molecular prognostic biomarker in kidney cancer that could guide therapy.

The study was funded by National Cancer Institute grants R01CA104505, R01CA136665 and R01CA104505-05S1; the David & Lois Stulberg Endowed Fund for Kidney Cancer Research; Mr. and Mrs. Ompal Chauhan Kidney Cancer Research Fund; Kidney Cancer Research at Mayo Clinic in Florida; James C. and Sarah K. Kennedy Mayo Clinic Research Career Development Award for Clinicians; Scheidel Foundation; Fraternal Order of Eagles Florida State Auxiliary, and a grant for rare cancers from Dr. Ellis and Dona Brunton.

###

About Mayo Clinic Cancer Center

As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 507-538-7623.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.com and http://www.mayoclinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Public release date: 30-Apr-2013
[ | E-mail | Share ]

Contact: Kevin Punsky
punsky.kevin@mayo.edu
904-953-2299
Mayo Clinic

JACKSONVILLE, Fla. Researchers at Mayo Clinic's campus in Florida have discovered a protein that is overly active in every human sample of kidney cancer they examined. They also found that an experimental drug designed to block the protein's activity significantly reduced tumor growth in animals when used alone. Combining it with another drug already used to treat the cancer improved the effectiveness of both.

The findings, reported in the April 30 online issue of Clinical Cancer Research, offer a much-needed potential new direction for the treatment of clear cell renal cell carcinoma, which accounts for almost 85 percent of kidney cancer cases in the United States. More than 57,000 diagnoses of kidney cancer occur yearly in the U.S. with greater than 13,000 deaths.

"There is a clear need for new therapies for this common cancer. With very few exceptions, patients inevitably become resistant to all available treatments," says the study's senior investigator, molecular biologist John Copland, Ph.D.

Their findings might be relevant to the treatment of other cancers, says Christina von Roemeling, the study's lead author. The protein they identified is produced by the stearoyl CoA desaturase 1 (SCD1) gene, which has also been found to be over active in a number of other cancers, including lung, stomach, breast, prostate, ovary and colon cancers.

"This is a gene that is highly active in a lot of other cancers and it may be that the agent we tested could provide new clinical avenues in those cancers as well," von Roemeling says.

The experimental drug, A939572, is a targeted inhibitor of SCD1 protein. "We found it to be incredibly specific to cancer cells in laboratory mice treated with the agent," Dr. Copland says. "But these are early days in the testing of this agent for cancer."

Not only is SCD1 active in some cancers, it also is being investigated for its role in promoting obesity and diabetes, the researchers say. Scientists are also testing A939572 as an antidote to those conditions.

The Mayo Clinic scientists performed a genome screen of tissue samples from 150 kidney cancer patient tissue samples, which represented all stages of cancer progression, to identify genes that are significantly overexpressed, compared to noncancerous tissue samples. SCD1 was one of their top finds.

They then disabled SCD1 in laboratory kidney cancer cells and found that the tumor cells stopped growing and a large percentage died.

Next, researchers tested A939572 and the federally approved kidney cancer drug temsirolimus. They found that using either agent alone cut tumor growth by up to 25 percent in mice studies, but using both drugs together, and at lower doses, reduced it 60 to 70 percent.

"The synergy between the drugs was very striking, suggestive of significant clinical benefit in patients," Dr. Copland says.

Von Roemeling says that SCD1 protein expression offers a novel molecular prognostic biomarker in kidney cancer that could guide therapy.

The study was funded by National Cancer Institute grants R01CA104505, R01CA136665 and R01CA104505-05S1; the David & Lois Stulberg Endowed Fund for Kidney Cancer Research; Mr. and Mrs. Ompal Chauhan Kidney Cancer Research Fund; Kidney Cancer Research at Mayo Clinic in Florida; James C. and Sarah K. Kennedy Mayo Clinic Research Career Development Award for Clinicians; Scheidel Foundation; Fraternal Order of Eagles Florida State Auxiliary, and a grant for rare cancers from Dr. Ellis and Dona Brunton.

###

About Mayo Clinic Cancer Center

As a leading institution funded by the National Cancer Institute, Mayo Clinic Cancer Center conducts basic, clinical and population science research, translating discoveries into improved methods for prevention, diagnosis, prognosis and therapy. For information on cancer clinical trials, call 507-538-7623.

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.com and http://www.mayoclinic.org/news.

Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.

---

[ | E-mail | Share ]

?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

Source: http://www.eurekalert.org/pub_releases/2013-04/mc-mcf042913.php

kanye west Univision josh hamilton Susan Rice the Who jon bon jovi jon bon jovi

Orb made 7-2 favorite for Kentucky Derby

Exercise rider Jenn Patterson rides Kentucky Derby entrant Orb for a workout at Churchill Downs Monday, April 29, 2013, in Louisville, Ky. (AP Photo/Garry Jones)

Exercise rider Jenn Patterson rides Kentucky Derby entrant Orb for a workout at Churchill Downs Monday, April 29, 2013, in Louisville, Ky. (AP Photo/Garry Jones)

Exercise rider Humberto Zamora rides Kentucky Derby hopeful Verrazano for a workout at Churchill Downs Wednesday, May 1, 2013, in Louisville, Ky. (AP Photo/Morry Gash)

Trainer Todd Pletcher watches morning workouts at Churchill Downs Wednesday, May 1, 2013, in Louisville, Ky. (AP Photo/Garry Jones)

An exercise rider takes Kentucky Derby hopeful Itsmyluckyday for a workout at Churchill Downs Wednesday, May 1, 2013, in Louisville, Ky. (AP Photo/Garry Jones)

Part-owner of Kentucky Derby hopeful Goldencents Rick Pitino, left, talks to jockey Kevin Krigger at Churchill Downs Wednesday, May 1, 2013, in Louisville, Ky. (AP Photo/Garry Jones)

LOUISVILLE, Ky. (AP) ? Orb has been made the early 7-2 favorite for the Kentucky Derby, with undefeated Verrazano the second choice in a full field of 20 horses.

Trained by Shug McGaughey, Orb drew the No. 16 post on Wednesday. Four horses have won from there, most recently Animal Kingdom two years ago. McGaughey is in racing's Hall of Fame, but the 62-year-old trainer has yet to win the Derby in six previous tries.

Orb comes into Saturday's big race on a four-race winning streak. He won the Florida Derby in his last start.

Wood Memorial winner Verrazano drew the No. 14 post and is the 4-1 second choice. The colt is one of a record-tying five starters trained by Todd Pletcher. He won his first and only Derby in 2010 with Super Saver.

Santa Anita Derby winner Goldencents is the third choice at 5-1 and will break from the No. 8 post. He's trained by Doug O'Neill, who won last year with I'll Have Another.

Another Pletcher horse, Revolutionary, is the fourth choice at 10-1 on the morning line set by Churchill Downs oddsmaker Mike Battaglia. The colt is ridden by Calvin Borel, a three-time Derby winner famous for riding the rail. Revolutionary drew the No. 3 post, leaving Borel close to his favorite route on the track.

Normandy Invasion is the fifth choice at 12-1.

The other 15 horses are all 15-1 or higher, including Pletcher's other horses ? Overanalyze (15-1), Palace Malice (20-1), and Charming Kitten (20-1).

Spiral Stakes winner Black Onyx drew the dreaded inside post and is one of five 50-1 shots in the field.

Oxbow and Will Take Charge will be the record 46th and 47th Derby starters for Hall of Fame trainer D. Wayne Lukas, a four-time Derby winner. Both are long shots ? Will Take Charge at 20-1 and Oxbow at 30-1.

The 21st horse on the points list is Fear the Kitten, an also eligible who would need a defection before 9 a.m. Friday, when Derby wagering opens, to get into the 1 ?-mile race.

Post time is 6:24 p.m. EDT Saturday.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/347875155d53465d95cec892aeb06419/Article_2013-05-01-Kentucky%20Derby/id-93fc114c01e34ce58f1d535eb4ff1452

lorax fisker karma super tuesday states shepard fairey is snooki pregnant snooki pregnant gbc

Morocco accuses Algeria and Polisario of destabilizing the Sahara ...

By Youssef El Kaidi

Morocco World News

Fez, April 30, 2013

It seems that the US withdrawal of its draft resolution to expand the mandate of the MINURSO to monitor human rights in the Sahara was disillusioning and traumatic to the Polisario and Algeria. Following the adoption by the UN Security Council of the resolution on the Moroccan Sahara by consensus?the resolution that makes no mention of a human rights monitoring mechanism in the Moroccan Sahara?the separatists in the southern provinces went into riots in Laayoune and Boujdour to provoke the security forces and instigate violence.

The US withdrawal of its draft resolution, which is perceived as a political victory for Morocco, puts Algeria and Polisario in an embarrassing situation. In response to this political victory, Algeria and Polisario plan to sow the seeds of discord and anarchy in the Moroccan Sahara by ?inciting minors to engage in clashes with Moroccan security forces to promote the claim that Morocco does not respect human rights,? the mayor of Laayoune Khalil Eddakhil said in a press conference on Monday.

The mayor added that there is information indicating that a number of ?young men benefit from training in the Tindouf camps (of Polisario in the Algerian territory) and then infiltrate Morocco?s southern provinces to carry out acts of sabotage.?

The plan to drag the region into instability, of which Morocco is fully aware, is carried out by the separatists in the cities of the Moroccan Sahara. These individuals were not arrested despite the damage that they caused to public property in these cities. ?No one was arrested despite the acts of vandalism and serious damage that occurred to public property, as well as the injury of a number of members of the security forces who were pelted with stones,? says Mr. Khalil Eddakhil who also stressed that ?Morocco is committed to the policy of restraint so as to not give the opponents of its territorial integrity excuses that they later may use against it.?

? Morocco World News. All Rights Reserved. This material may not be published, rewritten or redistributed

Source: http://www.moroccoworldnews.com/2013/04/89065/morocco-accuses-algeria-and-polisario-of-destabilizing-the-sahara/

indiana autoimmune disease news channel 9 insanity workout mass effect 3 launch trailer yelp huntsville al

West, Texas, 'will come back,' says mayor

MADRID, April 30 (Reuters) - Teams for Tuesday's Champions League semi-final second leg between Real Madrid and Borussia Dortmund at the Bernabeu: Real Madrid: 41-Diego Lopez; 15-Michael Essien, 4-Sergio Ramos, 2-Raphael Varane, 5-Fabio Coentrao; 19-Luka Modric, 14-Xabi Alonso; 22-Angel Di Maria, 10-Mesut Ozil, 7-Cristiano Ronaldo; 20-Gonzalo Higuain Borussia Dortmund: 1-Roman Weidenfeller; 26-Lukasz Piszczek, 4-Neven Subotic, 15-Mats Hummels, 29-Marcel Schmelzer; 8-Ilkay Guendogan, 6-Sven Bender; 16-Jakub Blaszczykowski, 10-Mario Goetze, 11-Marco Reus; 9-Robert Lewandowski Referee: Howard ...

Source: http://news.yahoo.com/mayor-says-blast-damaged-texas-172316517.html

illinois primary results acapulco mexico hines ward robert deniro mexico news the talented mr ripley weather new orleans